21 Nov 2017
// Ujjval Jauhari BUSINESS-STANDARD
http://www.business-standard.com/article/markets/cipla-shines-in-gloomy-pharma-pack-biggest-beneficiary-of-faster-approvals-117112200268_1.html
20 Nov 2017
// BUSINESS-STANDARD
http://www.business-standard.com/article/companies/cipla-gets-usfda-nod-to-market-generic-version-of-cancer-drug-dacogen-117112000203_1.html
LOOKING FOR A SUPPLIER?